These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1797144

  • 21. Metabolism of cerebroside sulfate and subcellular distribution of its metabolites in cultured skin fibroblasts from controls, metachromatic leukodystrophy, and globoid cell leukodystrophy.
    Inui K, Furukawa M, Okada S, Yabuuchi H.
    J Clin Invest; 1988 Feb; 81(2):310-7. PubMed ID: 3339122
    [Abstract] [Full Text] [Related]

  • 22. [14C]Methylamine accumulation in cultured human skin fibroblasts--a biochemical test for lysosomal storage and lysosomal diseases.
    Kopitz J, Gerhard C, Höfler P, Cantz M.
    Clin Chim Acta; 1994 Jun; 227(1-2):121-33. PubMed ID: 7955409
    [Abstract] [Full Text] [Related]

  • 23. The effects of sucrose loading on lysosomal hydrolases.
    Kato T, Okada S, Yutaka T, Yabuuchi H.
    Mol Cell Biochem; 1984 Jun; 60(1):83-98. PubMed ID: 6708943
    [Abstract] [Full Text] [Related]

  • 24. Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts.
    Hollemans M, Elferink RO, De Groot PG, Strijland A, Tager JM.
    Biochim Biophys Acta; 1981 Apr 22; 643(1):140-51. PubMed ID: 7236683
    [Abstract] [Full Text] [Related]

  • 25. Storage problems in lysosomal diseases.
    Heard JM, Bruyère J, Roy E, Bigou S, Ausseil J, Vitry S.
    Biochem Soc Trans; 2010 Dec 22; 38(6):1442-7. PubMed ID: 21118104
    [Abstract] [Full Text] [Related]

  • 26. Drug-induced intralysosomal storage of sulfated glycosaminoglycans (GAGs): a methodical pitfall occurring with acridine derivatives.
    Lüllmann-Rauch R.
    Exp Toxicol Pathol; 1994 Oct 22; 46(4-5):315-22. PubMed ID: 7894242
    [Abstract] [Full Text] [Related]

  • 27. Galactosylceramide- and lactosylceramide-loading studies in cultured fibroblasts from normal individuals and patients with globoid cell leukodystrophy (Krabbe's disease) and GM1-gangliosidosis.
    Kobayashi T, Shinnoh N, Goto I, Kuroiwa Y, Okawauchi M, Sugihara G, Tanaka M.
    Biochim Biophys Acta; 1985 Jul 31; 835(3):456-64. PubMed ID: 3926002
    [Abstract] [Full Text] [Related]

  • 28. Detection of distribution of copper inside and outside of lysosomes in cultured hepatolenticular degeneration fibroblasts by electron probe X-ray microanalysis.
    Liu W, Li JY, Jin J, Zuo J.
    Hepatobiliary Pancreat Dis Int; 2003 May 31; 2(2):270-3. PubMed ID: 14599982
    [Abstract] [Full Text] [Related]

  • 29. Biosynthesis of lysosomal proteinases in health and disease.
    Mach L.
    Biol Chem; 2002 May 31; 383(5):751-6. PubMed ID: 12108539
    [Abstract] [Full Text] [Related]

  • 30. Tissue culture loading test with storage granules from animal models of neuronal ceroid-lipofuscinosis (Batten disease): testing their lysosomal degradability by normal and Batten cells.
    Elleder M, Drahota Z, Lisá V, Mares V, Mandys V, Müller J, Palmer DN.
    Am J Med Genet; 1995 Jun 05; 57(2):213-21. PubMed ID: 7668332
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Effect of amines on the pH in the lysosomes of 3T3 cells].
    Sorkin AD, Bogdanova NP, Nikol'skiĭ NN, Sorokin AB.
    Tsitologiia; 1985 Feb 05; 27(2):203-8. PubMed ID: 3992660
    [Abstract] [Full Text] [Related]

  • 33. Accumulation of sialic acid in endocytic compartments interferes with the formation of mature lysosomes. Impaired proteolytic processing of cathepsin B in fibroblasts of patients with lysosomal sialic acid storage disease.
    Schmid JA, Mach L, Paschke E, Glössl J.
    J Biol Chem; 1999 Jul 02; 274(27):19063-71. PubMed ID: 10383408
    [Abstract] [Full Text] [Related]

  • 34. Lysosomal enzymes in medium from cultured skin fibroblasts from normal individuals and patients with lysosomal diseases.
    Hultberg B, Sjöblad S.
    Clin Chim Acta; 1977 Oct 01; 80(1):79-86. PubMed ID: 409577
    [Abstract] [Full Text] [Related]

  • 35. Possible use of CSF glycosphingolipids for the diagnosis and therapeutic monitoring of lysosomal storage diseases.
    Kaye EM, Ullman MD, Kolodny EH, Krivit W, Rischert JC.
    Neurology; 1992 Dec 01; 42(12):2290-4. PubMed ID: 1461381
    [Abstract] [Full Text] [Related]

  • 36. Lysosomal storage disease: revealing lysosomal function and physiology.
    Parkinson-Lawrence EJ, Shandala T, Prodoehl M, Plew R, Borlace GN, Brooks DA.
    Physiology (Bethesda); 2010 Apr 01; 25(2):102-15. PubMed ID: 20430954
    [Abstract] [Full Text] [Related]

  • 37. Mucolipidosis type IV: the effect of increased lysosomal pH on the abnormal lysosomal storage.
    Kogot-Levin A, Zeigler M, Ornoy A, Bach G.
    Pediatr Res; 2009 Jun 01; 65(6):686-90. PubMed ID: 19247216
    [Abstract] [Full Text] [Related]

  • 38. Characterization of Human Dermal Fibroblasts in Fabry Disease.
    Lakomá J, Donadio V, Liguori R, Caprini M.
    J Cell Physiol; 2016 Jan 01; 231(1):192-203. PubMed ID: 26058984
    [Abstract] [Full Text] [Related]

  • 39. Fluorogenic Substrates for Visualizing Acidic Organelle Enzyme Activities.
    Harlan FK, Lusk JS, Mohr BM, Guzikowski AP, Batchelor RH, Jiang Y, Naleway JJ.
    PLoS One; 2016 Jan 01; 11(5):e0156312. PubMed ID: 27228111
    [Abstract] [Full Text] [Related]

  • 40. Resolution of lysosomes in living cells with a ratiometric molecular pH-meter.
    Li Z, Wu S, Han J, Yang L, Han S.
    Talanta; 2013 Sep 30; 114():254-60. PubMed ID: 23953468
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.